The test may also be used for asymptomatic people if they are tested twice over three days. Read More

The FDA previously cleared two similar products from the company designed to treat substance use disorder and opioid use disorder. Read More

Arrhythmia detection was similar in all age groups, including newborns and adolescents, regardless of the recording device, the company said. Read More

Researchers at Columbia University conducted a study of NGAL to screen for renal failure in COVID-19 patients, with encouraging results. Read More

Theradaptive hopes to “change the practice of medicine by enabling precise tissue regeneration in a way that was not previously possible,” a company spokesperson said. Read More

The test is indicated for asymptomatic women over 40. Read More

Roche expects to get the FDA’s approval for the new system in the third quarter of 2022. Read More

The modeling tool can predict the interactions of implants with electromagnetic fields. Read More

The implantable device allows the use of ultrasound for postoperative imaging, reducing the patient’s radiation exposure. Read More

The device received the FDA’s 510(k) clearance last December. Read More

The FDA approved a U.S. trial of the implant in July, which will enroll more than 350 patients with open-angle glaucoma. Read More